Announce Date | 09/25/2025 |
EPS Normalized Actual | $3.03 (Beat by $0.05) |
EPS GAAP Actual | $3.03 (Beat by $0.05) |
Revenue Actual | $17.5963B |
Revenue Surprise | Beat by $17596.3M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2029 | 18.17 | 13.28 | 17.70158 | 18.48796 | 2 |
Aug 2028 | 17.82 | 13.54 | 17.55341 | 18.58217 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Aug 2025) | 2.27 | 2.27 | 17.5963B | 6.77% | 17596.3M |
FQ2 2025 (May 2025) | 3.52 | 3.52 | 17.7279B | 7.11% | 17727.9M |
FQ1 2025 (Feb 2025) | 2.85 | 2.85 | 16.6593B | 5.16% | 16659.3M |
FQ4 2024 (Nov 2024) | 0.0035 | 0.0035 | 17.6895B | 100% | 17689.5M |
FQ3 2024 (Aug 2024) | 2.74 | 2.74 | 16.4058B | 2.56% | 16405.8M |
FQ2 2024 (May 2024) | 3.07 | 3.07 | 16.4668B | -0.59% | 16466.8M |
FQ1 2024 (Feb 2024) | 2.66 | 2.66 | 15.7995B | -0.09% | 15799.5M |
FQ4 2023 (Nov 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2028 (May 2028) | 4.45579 | -- | 4.38997 | 4.5341 | 4 |
FQ1 2028 (Feb 2028) | 3.43 | -- | 3.34378 | 3.48255 | 7 |
FQ4 2027 (Nov 2027) | 4.3 | -- | 4.19191 | 4.36588 | 6 |
FQ3 2027 (Aug 2027) | 3.64326 | -- | 3.58876 | 3.72058 | 11 |
FQ2 2027 (May 2027) | 3.9463 | -- | 3.88727 | 4.03006 | 15 |
FQ1 2027 (Feb 2027) | 3.38277 | -- | 3.31711 | 3.44673 | 6 |
FQ4 2026 (Nov 2026) | 4.24855 | -- | 4.185 | 4.33872 | 8 |
FQ3 2026 (Aug 2026) | 3.61432 | 37.19 | 3.54761 | 3.69322 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2028 (May 2028) | 21.02B | -- | 20.78B | 21.3B | 4 |
FQ1 2028 (Feb 2028) | 19.92B | -- | 19.53B | 20.15B | 6 |
FQ4 2027 (Nov 2027) | 20.56B | -- | 20.17B | 20.81B | 7 |
FQ3 2027 (Aug 2027) | 19.59B | -- | 19.36B | 19.91B | 9 |
FQ2 2027 (May 2027) | 19.2B | -- | 18.98B | 19.51B | 9 |
FQ1 2027 (Feb 2027) | 19.31B | -- | 19.02B | 19.59B | 8 |
FQ4 2026 (Nov 2026) | 19.97B | -- | 19.74B | 20.3B | 9 |
FQ3 2026 (Aug 2026) | 19.45B | 9.51 | 19.17B | 19.77B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | 2.27 | 2.27 | 100% | |
FQ2 2025 (May 2025) | 3.52 | 3.52 | 100% | |
FQ1 2025 (Feb 2025) | 2.85 | 2.85 | 100% | |
FQ4 2024 (Nov 2024) | 0.0035 | 0.0035 | 100% | |
FQ3 2024 (Aug 2024) | 2.74 | 2.74 | 100% | |
FQ2 2024 (May 2024) | 3.07 | 3.07 | 100% | |
FQ1 2024 (Feb 2024) | 2.66 | 2.66 | 100% | |
FQ4 2023 (Nov 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | $0B | $17.6B | $17596.3M | 100% |
FQ2 2025 (May 2025) | $0B | $17.73B | $17727.9M | 100% |
FQ1 2025 (Feb 2025) | $0B | $16.66B | $16659.3M | 100% |
FQ4 2024 (Nov 2024) | $0B | $17.69B | $17689.5M | 100% |
FQ3 2024 (Aug 2024) | $0B | $16.41B | $16405.8M | 100% |
FQ2 2024 (May 2024) | $0B | $16.47B | $16466.8M | 100% |
FQ1 2024 (Feb 2024) | $0B | $15.8B | $15799.5M | 100% |
FQ4 2023 (Nov 2023) | $0B | $0B | $0M | NAN% |